FindTrial
Sign In

Optimization of Antiviral Treatments for Chronic Hepatitis B to Improve Clinical Outcomes

Optimization of Antiviral Treatments for Chronic Hepatitis B to Improve Clinical Outcomes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002039
Enrollment
10000
Registered
2016-09-05
Start date
2016-03-24
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who diagnosed with chronic hepatitis B between January 1 1998 and December 31 2015 at Asan Medical Center

Exclusion criteria

Exclusion criteria: 1. patients who previously diagnosed hepatocellular carcinoma or concurrent HCC at diagnosis 2. patients who previously undewent liver transplantation

Design outcomes

Secondary

MeasureTime frame
transplant-free survival—

Primary

MeasureTime frame
Incidence of hepatocellular carcinoma—

Countries

Korea, Republic of

Contacts

Public ContactJihyun An

Asan Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026